Access Ultrasensitive Insulin only used on the DxI 9000 Access Immunoassay Analyzer, Catalog Number 33410
Published February 14, 2024 · Recall initiated: November 21, 2023
Summary
FDA records medical device Class II recall Z-0981-2024, published February 14, 2024 and initiated November 21, 2023. Recalling firm: Beckman Coulter, Inc.; Status: Ongoing; Reported quantity: 19,125 reagent packs; Lot: UDI/DI 15099590230623, Lot Numbers: 125533, 125589, 233656, 233919, 234055, 234339, 234388. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
There is an issue with the Access Ultrasensitive Insulin assay protocol file (APF) for use with the DxI 9000 Access Immunoassay Analyzer (APF 182 test definition version 6.7 and below). The Access Ultrasensitive Insulin APF applies an incorrect conversion factor when converting from system default units of ¿IU/mL to the International System of Units (SI units) of pmol/L.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Beckman Coulter, Inc.
- Distributor
- Worldwide distribution - US Nationwide and the countries of Australia, Austria, Belgium, Croatia, Czech Republic, France, Germany, Hungary, Ireland, Israel, Italy, Netherlands, New Zealand, Poland, Portugal, Slovakia, South Africa, Spain, Sweden, Switzerland, Taiwan, United Kingdom.
- Lot
- UDI/DI 15099590230623, Lot Numbers: 125533, 125589, 233656, 233919, 234055, 234339, 234388
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAROTOR ASSY-SW40, Reference Number 331302, when the rotors are installed in the following centrifuges: OptimaOctober 28, 2026
- FDAROTOR ASSY-SW41, Reference Number 331362, when the rotors are installed in the following centrifuges: OptimaOctober 28, 2026
- FDAIQ200 SPRINT, REF: 700-3322,700-3322RFB, 700-3325, 700-3326, B48997; IQ200 SELECT, REF: 700-3340, 700-3345,October 21, 2026
- FDADxU 840m Iris, REF: C76947; DxU 850m Iris, REF: C49513October 21, 2026
- FDABarco MDSC-8527 NXF, Part Number K9352421February 14, 2024
- FDADxI 9000 Access Immunoassay Analyzer running software version 1.16 or prior,February 14, 2024
Questions about this recall
Was Access Ultrasensitive Insulin only used on the DxI 9000 Access Immunoassay Analyzer, Catalog Number 33410 recalled?
Yes. FDA published recall Z-0981-2024 on February 14, 2024. Reported hazard: There is an issue with the Access Ultrasensitive Insulin assay protocol file (APF) for use with the DxI 9000 Access Immunoassay Analyzer (APF 182 test definition version 6.7 and below). The Access Ultrasensitive Insulin APF applies an incorrect conversion factor when converting from system default units of ¿IU/mL to the International System of Units (SI units) of pmol/L.
What should I do if I have this product?
Voluntary: Firm initiated · Letter